Investors Urged to Lead Reckitt Benckiser Class Action over Fraud Allegations

In a significant appeal to investors, the Rosen Law Firm has announced that individuals who purchased American Depositary Shares (ADSs) of Reckitt Benckiser Group PLC between January 13, 2021, and July 28, 2024, may have a chance to lead a class-action lawsuit concerning allegations of securities fraud. The deadline for potential lead plaintiffs is set for August 4, 2025.

The Background of Allegations

Reckitt Benckiser, known for brands like Enfamil, has been embroiled in controversy concerning the safety of its cow's milk-based infant formula. Specific allegations state that the company failed to disclose vital information about the risks associated with its product, particularly regarding preterm infants potentially developing necrotizing enterocolitis (NEC). This lack of transparency has led to concerns over Reckitt's financial performance and has spurred legal claims from affected consumers.

Legal representatives argue that Reckitt’s misleading communication over its business operations has caused investors to suffer financial damages when the true state of affairs became known. As such, investors who acquired Reckitt ADSs during the specified class period are encouraged to explore their legal options to seek compensation.

How to Participate

For those interested in participating in the class-action lawsuit, they can visit the Rosen Law Firm's dedicated webpage or reach out directly to Phillip Kim, Esq. Potential lead plaintiffs must act quickly, as moving the Court to serve as lead plaintiff must occur by the aforementioned deadline. Notably, participation in the action does not require upfront legal fees, as these can be arranged through a contingency fee agreement.

Why Choose Rosen Law Firm?

Rosen Law Firm prides itself on representing investors with a solid track record in securities class actions. The firm emphasizes the importance of choosing experienced legal counsel, as many firms offering notices may not have significant litigation experience. Rosen Law Firm has successfully handled numerous high-profile cases, recovering substantial amounts for investors over the years, with a notable settlement of over $438 million for clients in 2019 alone.

Conclusion

Investors who are affected by this situation are being urged to act swiftly to ensure their rights are protected. As the August 4 deadline approaches, interested parties have the opportunity to lead a class action that could potentially garner compensation for their losses. The pitfalls in selecting legal representation can be considerable, making the choice of a knowledgeable and experienced firm critical in navigating these complex legal waters. For continued updates on this unfolding case, follow the Rosen Law Firm on their social media channels or head to their website for more information.

For more details, please check out the following resources:

- Join the Reckitt class action: Rosen Law Firm Submission Page
- Contact legal representative Phillip Kim at 866-767-3653 or via email at [email protected].

Important Notes

It is crucial to understand that no class has officially been certified yet. Until this occurs, those interested are encouraged to seek counsel or remain passive participants in the action. Participation as a lead plaintiff does not dictate eligibility for recovery, allowing various paths for affected investors to consider.

Keep informed and take action to secure your position in this significant legal matter involving Reckitt Benckiser.